Are you ready to amplify your academic presence and connect with a global network of researchers? Join the Scholar Indexing Society and elevate your research to new heights!
Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation
Article Number: SIS869710AI300425
30th April, 2025
Author(s):
Tobias Reichlin et al. for the SINGLE SHOT CHAMPION Investigators
Abstract:
Background:
Pulmonary-vein isolation is effective for paroxysmal atrial fibrillation (AF). Pulsed field ablation (PFA) is a nonthermal method with potential safety advantages over cryoballoon ablation, but comparative efficacy data with continuous rhythm monitoring are limited.
Methods:
In this randomized noninferiority trial, 210 patients with symptomatic paroxysmal AF were assigned to PFA or cryoablation, with all receiving implantable cardiac monitors. The primary endpoint was atrial tachyarrhythmia recurrence between days 91–365 post-ablation. Noninferiority was assessed with a 20-percentage-point margin.
Results:
Recurrence occurred in 37.1% (PFA) vs. 50.7% (cryoablation) (difference: −13.6 percentage points; 95% CI: −26.9 to −0.3; P<0.001 for noninferiority, P=0.046 for superiority).
Safety events were rare (1.0% PFA vs. 1.9% cryoablation).
PFA procedures were shorter (mean 55 vs. 73 minutes).
Conclusions:
PFA was noninferior to cryoablation for AF recurrence and associated with fewer recurrences and shorter procedure times.